Pharmacies compounding Semaglutide raises concerns
The US Food and Drug Administration (FDA) recently warned two online suppliers to stop manufacturing unapproved versions of semaglutide (marketed as Ozempic for type 2 diabetes). 2; Wegovy for obesity) and tirzepatide (Mounjaro). With ongoing shortages of these two popular drugs, compounded versions have become popular. According to the FDA, compounding pharmacies are allowed to … Read more